Stockreport

Geron (GERN): Assessing Valuation After Leadership Changes to Drive RYTELO Growth and Strategic Transformation [Yahoo! Finance]

Geron Corporation  (GERN) 
Last geron corporation earnings: 3/12 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: geron.com/investors
PDF appointment of new faces who will be responsible for steering the commercialization of its blood cancer drug, RYTELO. These moves indicate the company's intent to streng [Read more]